Intrauterine devices, contraception, and mood changes: what to watch for
1Queen's University School of Medicine, Kingston, Ontario, Canada.
Summary
Hormonal changes during the reproductive life cycle and hormone therapies can cause mood swings and anxiety in women. Healthcare providers should discuss these potential psychological effects with patients considering hormonal treatments or contraception.
Area of Science:
- Reproductive Endocrinology
- Women's Health
- Psychoneuroendocrinology
Background:
- Endogenous hormone fluctuations across the reproductive life cycle can impact women's mood and anxiety levels.
- Hormone-based therapies, including contraception and menopause management, are linked to psychological side effects.
- These effects can negatively influence overall well-being and daily functioning.
Purpose of the Study:
- To review the association between endogenous hormone changes and psychological well-being in women.
- To examine the psychological adverse effects of hormone-based therapies.
- To inform clinicians about managing mood and anxiety issues related to hormonal treatments.
Main Methods:
- Literature review of studies on hormonal influences on mood and anxiety.
- Analysis of reported psychological effects associated with various hormone therapies.
- Clinical considerations for patient counseling.
Main Results:
- Natural hormonal shifts during the reproductive lifespan are correlated with mood disturbances and anxiety.
- Hormonal contraceptives, suppression therapies, and menopausal treatments may precipitate irritability, depression, and anxiety.
- Patient-reported outcomes highlight the significance of psychological tolerability.
Conclusions:
- Clinicians must proactively address potential mood and anxiety symptoms in women experiencing endogenous hormonal changes.
- Healthcare providers should counsel patients on the psychological risks associated with hormone-based therapies.
- Informed discussion regarding efficacy, safety, and tolerability is crucial for shared decision-making in hormonal treatments.
Related Concept Videos
Intrauterine Drug Delivery Systems
55
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
55
Birth Control Methods
7.0K
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
7.0K
Hormonal Regulation of the Menstrual Cycle
1.8K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
1.8K
Disorders of the Female Reproductive System
4.6K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
4.6K
Drugs for Treatment of Constipation-Predominant IBS
981
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
981
Ovarian Cycle
4.6K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
4.6K


